Barbara Kirschner to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Barbara Kirschner has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.140
-
Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
Score: 0.075
-
Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):28-33.
Score: 0.066